Skip to main content
Log in

Global trend of research and publications in endocrinology, diabetes, and metabolism: 1996–2021

  • Review Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

Background & Aims

Diabetes and related metabolic syndromes represent a significant global health challenge, with the global burden of diabetes increasing considerably since 1990. In this article, we examined the trend of publications in Endocrinology, Diabetes and Metabolism between 1996 and 2021, focusing on Asian countries.

Methods

We obtained and used the data from the Scopus database from the SCImago website (https://www.scimagojr.com/), on 1 April 2023, related to the subspecialty of Endocrinology, Diabetes and Metabolism for country rankings between 1996 and 2021. We did not include any data related to other medical specialties or other fields.

Results

There has been a steady rise in global publications on these subspecialties over the past decade, with the number of publications from Asian countries increasing significantly. Western Europe recorded the highest number of publications, followed by North America and Asia. The COVID-19 pandemic also contributed to a surge in publications in this field. In Asian countries, China and India have notably increased their global contribution to publications, with China emerging as the top Asian nation in 2021.

Conclusion

Our findings provide valuable insights into the research output from various countries and the productivity trends in Diabetes, Endocrinology and Metabolism-related research.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, Song X, Ren Y, Shan PF. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci Rep. 2020;10:14790. https://doi.org/10.1038/s41598-020-71908-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Diabetes. 2022. Accessed: 03/03/2023, 2022: https://www.who.int/news-room/fact-sheets/detail/diabetes. Accessed: 03/03/2023, 2022.

  3. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R, Committee IDFDA. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract 2019;157:107843. https://doi.org/10.1016/j.diabres.2019.107843

  4. Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al KJ. Epidemiology of type 2 diabetes - global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020;10:107–11. https://doi.org/10.2991/jegh.k.191028.001.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Misra A, Gopalan H, Jayawardena R, Hills AP, Soares M, Reza-Albarrán AA, Ramaiya KL. Diabetes in developing countries. J Diabetes. 2019;11(7):522–39. https://doi.org/10.1111/1753-0407.12913.

    Article  PubMed  Google Scholar 

  6. Hills AP, Misra A, Gill JMR, Byrne NM, Soares MJ, Ramachandran A, Palaniappan L, Street SJ, Jayawardena R, Khunti K, Arena R. Public health and health systems: implications for the prevention and management of type 2 diabetes in South Asia. Lancet Diabetes Endocrinol. 2018;6(12):992–1002. https://doi.org/10.1016/S2213-8587(18)30203-1.

    Article  PubMed  Google Scholar 

  7. Scimago Country and Journal Rank (SJR). (2022). Accessed: 03/03/2023, 2023. https://www.scimagojr.com/countryrank.php?category=2712 (2022). Accessed: 03/03/2023, 2023.

  8. Kambhampati SBS, Vaishya R, Vaish A. Unprecedented surge in publications related to COVID-19 in the first three months of pandemic: a bibliometric analytic report. J Clin Orthop Trauma. 2020;11:S304–6. https://doi.org/10.1016/j.jcot.2020.04.030.

    Article  PubMed  PubMed Central  Google Scholar 

  9. IDF Diabetes Atlas (10th Edition) Last accessed on 21 June 2023. https://diabetesatlas.org/

  10. Vivek R, Kalidasan R. Indian contribution on diabetes type 2–a scientometric analysis. Ann Romanian Soc Cell Biol. 2021:4572–85.

  11. Dayal D, Gupta BM, Raviteja KV, Pal R, Dhawan SM. Research on type 2 diabetes in India during 1982 to 2019: a comprehensive bibliometric assessment. J Diabetol. 2021;12:472–9. https://doi.org/10.4103/jod.jod_53_21.

    Article  Google Scholar 

  12. Emami Z, Khamseh ME, Madani NH, Hariri N, Alibeyk MR, Ghadiqolaei OA. Trend of scientific productions in the field of endocrinology and metabolism in Middle East countries during 2007-2013. Collnet J Scientometrics Info Manage. 2018;12:55–71. https://doi.org/10.1080/09737766.2017.1400751.

    Article  Google Scholar 

  13. Atlasi R, Tabatabaei-Malazy O, Bandarian F, Rezaei N, Khashayar P, Larijani B. Scientometric analysis of global scientific publications on COVID-19 and diabetes with an emphasis on middle eastern countries. Int J Endocrinol Metab. 2022;20:e120812. https://doi.org/10.5812/ijem-120812.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Gazzaz ZJ, Butt NS, Zubairi NA, Malik AA. Scientometric evaluation of research productivity on diabetes from the Kingdom of Saudi Arabia over the last two decades (2000-2019). J Diabetes Res. 2020;20:1514282. https://doi.org/10.1155/2020/1514282.

    Article  Google Scholar 

  15. Misra A. Diabetes-related research in India and other south Asian countries is inadequate requiring more funding, coaching and structure. Diabetes Metab Syndr. 2020;14(2):171–2. https://doi.org/10.1016/j.dsx.2020.02.008.

    Article  PubMed  Google Scholar 

  16. Ghosh A, et al. Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India study. Diabetes Metab Syndr. 2021;15(1):215–20. https://doi.org/10.1016/j.dsx.2020.12.033.

    Article  CAS  PubMed  Google Scholar 

  17. Misra A. Majorly resurgent and uncontrolled diabetes during COVID-19 era, and in the future can be contained in India. Diabetes Metab Syndr. 2021;15(5):102142. https://doi.org/10.1016/j.dsx.2021.05.015.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Vaishya R, et al. Diabetes and tuberculosis syndemic in India: a narrative review of facts, gaps in care and challenges. J Diabetes. 2023. https://doi.org/10.1111/1753-0407.13427.

  19. Pradhan Mantri Swasthya Suraksha Yojna. https://pmssy-mohfw.nic.in/index4.php?lang=1&level=0&linkid=81&lid=108. Last accessed on 6 March 2023

  20. Vaishya R, Gupta BM, Misra A, Mamdapurj GM, Vaish A. Global research in sarcopenia: high-cited papers, research institutions, funding agencies and collaborations, 1993-2022. Diabetes Metab Syndr. 2022;16:102654. https://doi.org/10.1016/j.dsx.2022.102654.

    Article  CAS  PubMed  Google Scholar 

  21. Vaishya R, Gupta BM, Kappi M, Vaish A. A scientometric analysis of India's publications in arthroplasty in the last two decades from the SCOPUS database. J Clin Orthop Trauma. 2022;34:102041. https://doi.org/10.1016/j.jcot.2022.102041.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

We are thankful to the SCImago website for providing very useful data for this research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raju Vaishya.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Data availability

All the raw data is available from the authors and can be provided, if need be.

Ethical approval

Not required.

Use of LLMs/AI technology

None

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Highlights

• Global publications on diabetes and associated diseases have steadily risen

• Asian countries, particularly China and India, have shown a good growth

• COVID-19 pandemic led to a surge in publications, with highest from Western Europe

Supplementary Information

ESM 1

(DOCX 12 kb)

ESM 2

(DOCX 26 kb)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vaishya, R., Misra, A., Nassar, M. et al. Global trend of research and publications in endocrinology, diabetes, and metabolism: 1996–2021. Int J Diabetes Dev Ctries (2023). https://doi.org/10.1007/s13410-023-01221-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13410-023-01221-4

Keywords

Navigation